Clinical trial
Curcumin in Patients With Mild to Moderate Alzheimer's Disease
NCT00099710 · John Douglas French Foundation, Other · Completed
Key facts
| NCT number | NCT00099710 |
|---|---|
| Title | Curcumin in Patients With Mild to Moderate Alzheimer's Disease |
| Official title | A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | John Douglas French Foundation, Other |
| Collaborators | Institute for the Study of Aging (ISOA) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Dietary Supplement |
| Interventions | Curcumin C3 Complex |
| Enrollment | 33 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Dec 20, 2004 |
| Last update posted | Dec 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: